Hims & Hers Health, Inc. Hims & Hers Health, Inc.

Hims & Hers Health, Inc.

HIMS

Pozycja w akcjach #2903
Hims & Hers Health, Inc. operates a comprehensive digital health platform that... Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
Cena akcji
$28.18
Kapitalizacja rynkowa
$6.34B
Zmiana (1 dzień)
0.59%
Zmiana (1 rok)
-43.40%
Kraj
US
Handel Hims & Hers Health, Inc. (HIMS)

Kategoria

Healthcare
Historia dywidend dla Hims & Hers Health, Inc. (HIMS)
Hims & Hers Health, Inc. (symbol giełdowy: HIMS) wypłaciła łącznie 0 dywidend.
Suma wszystkich dywidend (skorygowana o podziały akcji): 0.00
Wskaźnik dywidendy (TTM): 0
Wypłaty dywidend dla Hims & Hers Health, Inc. (HIMS) od 2026 do 2026
Roczne wypłaty dywidend
Rok Dywidenda (skorygowana o podziały akcji) Zmień
Za mało danych dla podanych dat.
Lista wszystkich wypłat dywidend
Rok Dywidenda Zmień
Za mało danych dla podanych dat.
Wypłaty dywidend firm podobnych lub konkurencyjnych